Effective quantitative real-time polymerase chain reaction analysis of the parkin gene (PARK2) exon 1–12 dosage

Por Shadrina, Maria I, Semenova, Elena V, Slominsky, Petr A, Bagyeva, Gulbahar H, Illarioshkin, Sergei N, Ivanova-Smolenskaia, Irina I, Limborska, Svetlana A
Publicado em 2007

Whole-Exome Sequencing in Searching for New Variants Associated With the Development of Parkinson’s Disease

Por Shulskaya, Marina V., Alieva, Anelya Kh., Vlasov, Ivan N., Zyrin, Vladimir V., Fedotova, Ekaterina Yu., Abramycheva, Natalia Yu., Usenko, Tatiana S., Yakimovsky, Andrei F., Emelyanov, Anton K., Pchelina, Sofya N., Illarioshkin, Sergei N., Slominsky, Petr A., Shadrina, Maria I.
Publicado no Front Aging Neurosci (2018)

Origin of the Mutations in the parkin Gene in Europe: Exon Rearrangements Are Independent Recurrent Events, whereas Point Mutations May Result from Founder Effects

Por Periquet, Magali, Lücking, Christoph B., Vaughan, Jenny R., Bonifati, Vincenzo, Dürr, Alexandra, De Michele, Giuseppe, Horstink, Martin W., Farrer, Matt, Illarioshkin, Sergei N., Pollak, Pierre, Borg, Michel, Brefel-Courbon, Christine, Denefle, Patrice, Meco, Giuseppe, Gasser, Thomas, Breteler, Monique M. B., Wood, Nick W., Agid, Yves, Brice, Alexis
Publicado em 2001